Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Carcinoid Tumors of the Stomach
Binstock, Aaron J., Johnson, C. Daniel, Stephens, David H., Lloyd, Ricardo V., Fletcher, Joel G.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 176 | Issue: 4 | Pages: 947-951

10.2214/ajr.176.4.1760947 | PMID 11264084 Get It

CT of Focal Nodular Hyperplasia of the Liver
Carlson, Stephanie K., Johnson, C. Daniel, Bender, Claire E., Welch, Timothy J.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 174 | Issue: 3 | Pages: 705-712

10.2214/ajr.174.3.1740705 | PMID 10701613 Get It

Primary tumors of the small intestine: CT evaluation
Dudiak, K M, Cd, Johnson, Stephens, DH

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 152 | Issue: 5 | Pages: 995-998

10.2214/ajr.152.5.995 | PMID 2705358 Get It

Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography
Nesbit, GM, Johnson, CD, James, EM, MacCarty, RL, Nagorney, DM, Bender, CE, Nesbit, Gary M. , MacCarty, RL

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 151 | Issue: 5 | Pages: 933-938

10.2214/ajr.151.5.933 | PMID 2845763 Get It

Cystic pancreatic tumors: CT and sonographic assessment
Cd, Johnson, Stephens, DH, Charboneau, J. William, Carpenter, H. A. , Welch, T.B.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 151 | Issue: 6 | Pages: 1133-1138

10.2214/ajr.151.6.1133 | PMID 3055888 Get It

Imaging of fibrolamellar hepatocellular carcinoma
Brandt, DJ, Cd, Johnson, Stephens, DH, Lh, Weiland

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 151 | Issue: 2 | Pages: 295-299

10.2214/ajr.151.2.295 | PMID 2839968 Get It

MR Imaging of the Breast in Patients with Invasive Lobular Carcinoma
Orel, Susan G., Heller, Rose, Reynolds, Carol, Czerniecki, Brian J. , Solin, Lawrence J., Schnall, Mitchell D. , Weinstein, Susan P.

Mayo Clinic

American Journal of Roentgenology | February 27, 2013 | Volume: 176 | Issue: 2 | Pages: 399-406

10.2214/ajr.176.2.1760399 | PMID 11159081 Get It

Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma
Sun, Gang , Tian, Jianmin, Gorospe, Emmanuel C., Johnson, Geoffrey B. , Lutzke, Lori S., Leggett, Cadman L. , Iyer, Prasad G. , Wang, Kenneth K, Johnson, Geoffrey B. , Hunt, Christopher H. , Johnson, Geoffrey B , Johnson, Geoffrey B , Leggett, Cadman L

Mayo Clinic

Journal of Gastroenterology and Hepatology | February 21, 2013 | Volume: 28 | Issue: 6 | Pages: 975-981

10.1111/jgh.12148 | PMID 23425230 Get It

AbstractBackground and AimsPositron emission tomography with computed tomography (PET/CT) has been used to detect metastasis in the diagnosis of esophageal adenocarcinoma (EAC). However, the utility of PET/CT to assess primary tumor for endoscopic resectability and prognosis in early EAC remains unclear. We conducted a retrospective study to determine the association of PET/CT findings with histopathological tumor invasion depth and survival outcomes.MethodsEAC patients who underwent PET/CT followed by endoscopic mucosal resection (EMR) were included. Pathology on EMR and survival outcomes from a prospectively maintained database was retrieved. Two radiologists independently reviewed the PET/CT using the following parameters: detection of malignancy, fluorodeoxyglucose (FDG) uptake intensity, FDG focality, FDG eccentricity, esophageal thickness, maximal standard uptake value (SUVmax), and SUVmax ratio (lesion/liver).ResultsThere were 72 eligible patients: 42 (58.3%) had T1a lesions, and 30 (41.7%) had ≥ T1b. Only SUVmax ratio was associated with tumor invasion depth (odds ratio = 2.77, 95% confidence interval 1.26–7.73, P = 0.0075). Using a cut‐off of 1.48, the sensitivity and specificity of SUVmax ratio for identification of T1a lesions were 43.3% and 80.9%, respectively. Adjusting the SUVmax ratio to 2.14, 16.7% (5/30) of ≥ T1b patients were identified without any false‐positive cases. Multivariate analysis showed SUVmax ratio, Charlson comorbidity index, and esophagectomy were independent predictors for survival.ConclusionsSUVmax ratio (lesion/liver) is more accurate in predicting endoscopic resectability and mortality for EAC than other PET/CT parameters and appears promising as a useful adjunct to the current diagnostic work‐up.
Cardiac Output Response to Exercise in Relation to Metabolic Demand in Heart Failure with Preserved Ejection Fraction
Abudiab, Muaz M. , Redfield, Margaret M. , Melenovský, Vojtěch , Olson, Thomas P. , Johnson, Bruce D. , Kass, David A. , Borlaug, Barry A. , Melenovský, Vojtěch

Mayo Clinic

European Journal of Heart Failure | February 21, 2013 | Volume: 15 | Issue: 7 | Pages: 776-785

10.1093/eurjhf/hft026 | PMID 23426022 Get It

Abstract Aims Exercise intolerance is a hallmark of heart failure with preserved ejection fraction (HFpEF), yet its mechanisms remain unclear. The current study sought to determine whether increases in cardiac output (CO) during exercise are appropriately matched to metabolic demands in HFpEF. Methods and results Patients with HFpEF (n = 109) and controls (n = 73) exercised to volitional fatigue with simultaneous invasive (n = 96) or non-invasive (n = 86) haemodynamic assessment and expired gas analysis to determine oxygen consumption (VO2) during upright or supine exercise. At rest, HFpEF patients had higher LV filling pressures but similar heart rate, stroke volume, EF, and CO. During supine and upright exercise, HFpEF patients displayed lower peak VO2 coupled with blunted increases in heart rate, stroke volume, EF, and CO compared with controls. LV filling pressures increased dramatically in HFpEF patients, with secondary elevation in pulmonary artery pressures. Reduced peak VO2 in HFpEF patients was predominantly attributable to CO limitation, as the slope of the increase in CO relative to VO2 was 20% lower in HFpEF patients (5.9 ± 2.5 vs. 7.4 ± 2.6 L blood/L O2, P = 0.0005). While absolute increases in arterial–venous O2 difference with exercise were similar in HFpEF patients and controls, augmentation in arterial–venous O2 difference relative to VO2 was greater in HFpEF patients (8.9 ± 3.4 vs. 5.5 ± 2.0 min/dL, P < 0.0001). These differences were observed in the total cohort and when upright and supine exercise modalities were examined individually. Conclusion While diastolic dysfunction promotes congestion and pulmonary hypertension with stress in HFpEF, reduction in exercise capacity is predominantly related to inadequate CO relative to metabolic needs.
Rebuttal: Aortic regurgitation and device closure of ASD or PFO
Loar, Robert W. , Johnson, Jonathan N. , Taggart, Nathaniel W.

Mayo Clinic

Catheterization and Cardiovascular Interventions | February 19, 2013 | Volume: 85 | Issue: 1 | Pages: 179-179

10.1002/ccd.24876 | PMID 23420681 Get It